{"id":"ID-015","kind":"order","level":"sector-regulator","jurisdiction":"Idaho","state":"ID","metro":"","industry":"","agency":"","eco":"","issuer":"Idaho State Board of Medicine (implementing Idaho State Board of Pharmacy Temporary Rule 704)","authority":"Board of Pharmacy temporary rulemaking under the extreme emergency declaration; Board of Medicine licensing authority","instrument":"Emergency Guidelines Regarding Chloroquine, Hydroxychloroquine, and Azithromycin (Temporary Rule 704, Medication Limitations)","title":"Idaho State Board of Medicine Emergency Guidelines Regarding Chloroquine, Hydroxychloroquine, and Azithromycin","dateIssued":"2020-03-27","effective":"2020-03-26 (Rule 704)","end":"Not stated","startDate":"2020-03-26","endDate":"2020-06-30","quarters":["2020Q2"],"types":["HC","SUPPLY"],"addressees":["Board of Medicine licensees","pharmacies"],"clause":"Rule 704. Medication Limitations. 01. No prescription for chloroquine or hydroxychloroquine may be dispensed unless all of the following apply: a. The prescription bears a written diagnosis from the prescriber consistent with the evidence for its use; b. The prescription is limited to no more than a fourteen (14) day supply; and c. No refills may be permitted unless a new prescription is furnished.... 02. No prescription for oral azithromycin may be dispensed unless... limited to no more than a five (5) day supply.","enforcement":"Licensing discipline; \u0027Idaho Board of Medicine licensees should conform their prescribing practices to align with Temporary Rule 704\u0027","functions":["SC drug allocation","PR prescribing practices of physician practices and pharmacies"],"notes":"Sector-regulator instrument (Boards of Medicine and Pharmacy). Text layer read.","sourceUrl":"https://coronavirus.idaho.gov/wp-content/uploads/2020/03/BOM-Emergency-Guidelines-Regarding-BOP-Rule-704-03-27-2020.pdf","snapshot":"https://web.archive.org/web/20200514115702/https://coronavirus.idaho.gov/wp-content/uploads/2020/03/BOM-Emergency-Guidelines-Regarding-BOP-Rule-704-03-27-2020.pdf","fileExists":true,"fileBytes":34755,"grade":"primary","character":"","description":"","collection":"ID","url":"/library/ID-015","exhibitUrl":"/exhibit/ID-015","citation":"Idaho State Board of Medicine (implementing Idaho State Board of Pharmacy Temporary Rule 704), Emergency Guidelines Regarding Chloroquine, Hydroxychloroquine, and Azithromycin (Temporary Rule 704, Medication Limitations) (Mar. 27, 2020) (Ex. ID-015)","stateName":"Idaho","related":[]}